Yachao Cui Selected Research

Immunotherapy

1/2024	Characterization of immunogenic cell death regulators predicts survival and immunotherapy response in lung adenocarcinoma.
1/2023	The E3 ubiquitin ligase RBCK1: Implications in the tumor immune microenvironment and antiangiogenic therapy of glioma.
1/2021	Characterization of m6A RNA Methylation Regulators Predicts Survival and Immunotherapy in Lung Adenocarcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yachao Cui Research Topics

Disease

3	Neoplasms (Cancer) 01/2023 - 01/2021
2	Adenocarcinoma of Lung 01/2024 - 01/2021
1	Inflammation (Inflammations) 12/2023
1	Glioma (Gliomas) 01/2023
1	Colorectal Neoplasms (Colorectal Cancer) 01/2023
1	Carcinogenesis 01/2021

Drug/Important Bio-Agent (IBA)

2	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2023
1	NF-kappaB-Inducing KinaseIBA 12/2023
1	Monocyte Chemoattractant ProteinsIBA 01/2023
1	UbiquitinIBA 01/2023
1	TNF Receptor-Associated Factor 6 (TRAF6)IBA 01/2023
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2023
1	Immunologic Factors (Immunomodulators)IBA 01/2023
1	Ligases (Synthetase)IBA 01/2023
1	Transcription Factors (Transcription Factor)IBA 01/2023
1	NF-kappa B (NF-kB)IBA 01/2023
1	6-methyladenineIBA 01/2021

Therapy/Procedure

3	Immunotherapy 01/2024 - 01/2021
2	Therapeutics 01/2023 - 01/2021